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Left common iliac vein compression by the right common iliac
artery was first recognized as a potential nidus for symptomatic left
leg chronic venous disease (CVD) in 1851.1 This anatomic curi-
osity, called a nonthrombotic iliac vein lesion (NIVL) by Raju et al,
has since been identified in up to 66% of the population2 and can be
associated with intraluminal fibrosis and webs at the compression
site. Only rarely (1% to 5% of cases), however, are NIVLs consid-
ered an independent cause of symptoms. More commonly, NIVLs
are credited with predisposing to left iliofemoral deep vein throm-
bosis. Their functional significance is acknowledged by vascular
interventionalists who treat NIVLs with percutaneous balloon
angioplasty and stents (PTAS).
Raju et al report a large clinical experience of 319 patients in
which NIVLs, independent of thrombotic complications, resulted
in symptomatic CVD that was successfully treated with PTAS. The
authors emphasize that (1) intravascular ultrasound (IVUS) is the
best imaging modality for identifying NIVLs, (2) clinically signif-
icant NIVLs are not unique to the left common iliac vein, (3)
accepted criteria such as venous hypertension or stenoses and/or
collaterals on venograms are not reliable for diagnosing NIVLs,
and (4) treatment of NIVLs results in symptomatic relief in 75% to
80% of patients at early andmid-term follow-up and independently
promotes venous ulcer healing.
Aspects of this report, however, raise important questions that
require further consideration. First, the lack of difference in the
clinical outcome between patients with and without valvular reflux
raises questions about the role of reflux in CVD. The authorssuggest that NIVLs may be permissive lesions that become morbid
only when other poorly defined cofactors are present. Is venous
reflux a contributing factor for symptomatic CVD, or is reflux
simply a concomitant sign of severe CVD?
Second, the concept that clinically significant NIVLs occur at
several locations in the iliac veins will require independent verifi-
cation.
Third, this study holds significant clinical promise for many
patients with venous ulcers. However, it also raises important
questions about the etiology of venous ulcers.
Finally, and perhaps most importantly, it remains to be seen
whether the authors’ success in identifying this highly selected
group of patients with NIVLs can be replicated by others. If so, the
increasing availability of IVUS and endovascular interventions
should translate into a significant improvement in the lives of many
CVD patients. However, attention to patient selection and further
investigation into the pathophysiology of this heretofore poorly
appreciated aspect of CVD will be required to realize the full
clinical promise of this report.
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